Robert Kennedy

VP Corporate Relations at Kazia Therapeutics

Robert Kennedy has extensive experience in corporate relations and sales. Robert started their career in 1998 as a Managing Director at ABN AMRO Bank N.V., where they worked on Japanese equities until 2000. Robert then moved on to roles at WI Carr, Crédit Agricole, and Collins Stewart Inc, where they continued to specialize in equities sales and management. In 2008, they joined CIMB as a Managing Director before transitioning to Panmure Gordon in 2009, where they worked on the UK equities desk. In 2010, they became the Chief at BBY Ltd until 2013. From 2012 to 2014, they worked as Director of U.S. Sales at Enclave Capital. In 2014, they joined Novogen Limited as VP of Corporate Relations and later took on the role of Managing Partner at Columbus Circle Corporate Relations.

From 1975 to 1977, Robert Kennedy attended RMIT University, where they focused on Journalism. Additionally, they obtained certifications in Series 7, Series 24, and Series 63 from the Financial Industry Regulatory Authority (FINRA).

Location

New York, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Kazia Therapeutics

3 followers

Kazia Therapeutics is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. Headquartered in Sydney, Australia, Kazia Therapeutics collaborates with leading scientists, clinicians, and investors around the world.


Industries

Headquarters

Sydney, Australia

Employees

11-50

Links